Robert LaCaze

home / authors / robert-lacaze

Member of the Executive Committee of Bayer AG’s Pharmaceuticals Division and Head of the Oncology Strategic Business Unit

Articles

When Innovation Outpaces HTA, Access Struggles to Keep Up

When Innovation Outpaces HTA, Access Struggles to Keep Up

September 14th 2021

Scientific advances are benefiting cancer patients, but it will take a pandemic-like response to ensure patients everywhere have access.